The Stroke Treatment Academic Industry Roundtable XII included a workshop to discuss the
most promising approaches to improve outcome from acute stroke. The workshop brought …

STAIR XII (12th Stroke Treatment Academy Industry Roundtable) included a workshop to
discuss the priorities for advancements in neuroimaging in the diagnostic workup of acute …

In April 2022, the long-running lockdown in Shanghai, China, due to the COVID-19
pandemic led to significant restrictions on the production of iodinated contrast media (ICM) …

The therapeutic focus in acute ischemic stroke over the last 2.5 decades has been to
balance the benefits of rapid reperfusion therapy with the risks of treatment-related …

Since the publication of the landmark thrombectomy trials in 2015, the field of endovascular
therapy for ischemic stroke has been rapidly growing. The very low number needed to treat …

The management of acute ischemic stroke is changing. Over the period of 2010–2050, the
number of incident strokes is expected to be more than double. Rapid access to mechanical …

Background The ANGIOCAT trial showed a clinical benefit of direct to angiography suite
(DTAS) for patients with large vessel occlusion (LVO) stroke admitted within 6 hours after …

Distal medium vessel occlusions (DMVOs) are thought to cause as many as 25% to 40% of
all acute ischemic strokes and may result in substantial disability amongst survivors …

Background The endovascular treatment procedure in tandem occlusions (TO) is complex
compared to single occlusion (SO) and optimal management remains uncertain. The aim of …

Background Large vessel recanalization (LVR) before endovascular therapy (EVT) for acute
large vessel ischemic strokes is a poorly understood phenomenon. Better understanding of …